We compared the effects of peripheral Freund's Complete Adjuvant (CFA) and formalin injection on spinal microglia activation. Both qualitative and quantitative analyses showed signs of microglia activation on the ipsilateral side of the lumbar dorsal horn on day 3, day 7 and day 14 after formalin injection. However, significant microglia morphological alteration was not found in the CFA model. At the injection site in the paw, CFA injection induced considerably more inflammation than formalin injection. Although spinal microglia might be activated in inflammatory pain models, morphologically, spinal microglia activation was not closely correlated with peripheral inflammation.
Introduction
Several laboratories have recently demonstrated that activated glia (microglia and astrocytes) in the spinal cord are key players in the induction and maintenance of pathological pain (Watkins et al., 2001; Tsuda et al., 2003; McMahon et al., 2005; Inoue,2006) . Spinal cord glia activation as detected with immunohistochemical markers for activated microglia and astrocytes has been demonstrated in almost all animal pain models, including neuropathic, traumatic injury, inflammatory, and bone cancer pain models (Gehrmann et al., 1991; Colburn et al., 1997; Molander et al., 1997; Popovich et al., 1997; Coyle, 1998; Fu et al., 1999; Sweitzer et al., 1999; Hashizume et al., 2000a,b; Honore et al., 2000; Raghavendra et al., 2004) . These exaggerated pain states are blocked by drugs that disrupt glial activation (Watkins et al., 1997; Hashizume et al., 2000b; Milligan et al., 2000 Milligan et al., , 2003 Sweitzer et al., 2001; Raghavendra et al., 2003; Ledeboer et al., 2005) .
In neuropathic pain models, the temporal pattern of microglia activation as demonstrated with OX-42 immunohistochemistry (which labels complement receptor C3bi, also known as CD11b) is similar to the pattern of increased pain behavior. These previous time course experiments showed microglia activation in the superficial dorsal horn on the nerve injured side as early as 24 h after peripheral nerve injury, which reached a maximum 7 to 14 days after injury (Colburn et al., 1997; Coyle, 1998; Hashizume et al., 2000a) .
While the involvement of microglia in neuropathic pain is convincing, the involvement of microglia in inflammatory pain models is still questionable. Raghavendra et al. reported an increase of OX-42 immunostaining and other microglia activation marker mRNAs in the lumbar spinal cord following injection of Complete Freund's Adjuvant (CFA) into the rat hind paw, correlating with microglia activation and the enhancement of pain (Raghavendra et al., 2004) . However, several other studies were unable to find the increase of OX-42 immunoreactivity over a similar time course with the same stimulus or with another inflammatory chemical irritant, mustard oil (Molander et al., 1997; Honore et al., 2000; Zhang et al., 2003; Clark et al., 2007) . Spinal injection of the glial metabolic inactivator fluorocitrate (which can block astrocyte function, but the effects of which on microglia are unknown) attenuated ipsilateral hyperalgesia and bilateral
